Reversal of Hyperlipidemia and Lipodystrophy in Patients Switching Therapy to Nelfinavir
- 1 May 2000
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (1) , 78-79
- https://doi.org/10.1097/00126334-200005010-00014
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Lipodystrophy in patients naive to HIV protease inhibitorsAIDS, 1999
- Studies of Body Composition and Fat Distribution in HIV-Infected and Control SubjectsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapyAIDS, 1999
- Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patientsAIDS, 1998
- “Buffalo hump” in HIV-1 infectionThe Lancet, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Indinavir-associated lipodystrophyAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998